42 related articles for article (PubMed ID: 8081385)
1. Genetic heterogeneity among Fanconi anemia heterozygotes and risk of cancer.
Berwick M; Satagopan JM; Ben-Porat L; Carlson A; Mah K; Henry R; Diotti R; Milton K; Pujara K; Landers T; Dev Batish S; Morales J; Schindler D; Hanenberg H; Hromas R; Levran O; Auerbach AD
Cancer Res; 2007 Oct; 67(19):9591-6. PubMed ID: 17909071
[TBL] [Abstract][Full Text] [Related]
2. Correction: Insights into the genetic epidemiology of Crohn's and rare diseases in the Ashkenazi Jewish population.
Rivas MA; Avila BE; Koskela J; Huang H; Stevens C; Pirinen M; Haritunians T; Neale BM; Kurki M; Ganna A; Graham D; Glaser B; Peter I; Atzmon G; Barzilai N; Levine AP; Schiff E; Pontikos N; Weisburd B; Lek M; Karczewski KJ; Bloom J; Minikel EV; Petersen BS; Beaugerie L; Seksik P; Cosnes J; Schreiber S; Bokemeyer B; Bethge J; ; ; ; Heap G; Ahmad T; Plagnol V; Segal AW; Targan S; Turner D; Saavalainen P; Farkkila M; Kontula K; Palotie A; Brant SR; Duerr RH; Silverberg MS; Rioux JD; Weersma RK; Franke A; Jostins L; Anderson CA; Barrett JC; MacArthur DG; Jalas C; Sokol H; Xavier RJ; Pulver A; Cho JH; McGovern DPB; Daly MJ
PLoS Genet; 2019 May; 15(5):e1008190. PubMed ID: 31145742
[TBL] [Abstract][Full Text] [Related]
3. A C57BL/6J Fancg-KO Mouse Model Generated by CRISPR/Cas9 Partially Captures the Human Phenotype.
Shah R; van den Berk PCM; Pritchard CEJ; Song JY; Kreft M; Pilzecker B; Jacobs H
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446306
[TBL] [Abstract][Full Text] [Related]
4. SIK2 kinase synthetic lethality is driven by spindle assembly defects in FANCA-deficient cells.
Chan KK; Abdul-Sater Z; Sheth A; Mitchell DK; Sharma R; Edwards DM; He Y; Nalepa G; Rhodes SD; Clapp DW; Sierra Potchanant EA
Mol Oncol; 2022 Feb; 16(4):860-884. PubMed ID: 34058059
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Fanconi Anemia-Associated Head and Neck Cancer: Opportunities to Improve Outcomes.
Lee RH; Kang H; Yom SS; Smogorzewska A; Johnson DE; Grandis JR
Clin Cancer Res; 2021 Oct; 27(19):5168-5187. PubMed ID: 34045293
[TBL] [Abstract][Full Text] [Related]
6. Characterization and genotype-phenotype correlation of patients with Fanconi anemia in a multi-ethnic population.
Steinberg-Shemer O; Goldberg TA; Yacobovich J; Levin C; Koren A; Revel-Vilk S; Ben-Ami T; Kuperman AA; Zemer VS; Toren A; Kapelushnik J; Ben-Barak A; Miskin H; Krasnov T; Noy-Lotan S; Dgany O; Tamary H
Haematologica; 2020 Jul; 105(7):1825-1834. PubMed ID: 31558676
[TBL] [Abstract][Full Text] [Related]
7. FANCC Dutch founder mutation in a Mennonite family from Tamaulipas, México.
García-de Teresa B; Frias S; Molina B; Villarreal MT; Rodriguez A; Carnevale A; López-Hernández G; Vollbrechtshausen L; Olaya-Vargas A; Torres L
Mol Genet Genomic Med; 2019 Jun; 7(6):e710. PubMed ID: 31044565
[TBL] [Abstract][Full Text] [Related]
8. Update of the human and mouse Fanconi anemia genes.
Dong H; Nebert DW; Bruford EA; Thompson DC; Joenje H; Vasiliou V
Hum Genomics; 2015 Nov; 9():32. PubMed ID: 26596371
[TBL] [Abstract][Full Text] [Related]
9. Fanconi anemia gene editing by the CRISPR/Cas9 system.
Osborn MJ; Gabriel R; Webber BR; DeFeo AP; McElroy AN; Jarjour J; Starker CG; Wagner JE; Joung JK; Voytas DF; von Kalle C; Schmidt M; Blazar BR; Tolar J
Hum Gene Ther; 2015 Feb; 26(2):114-26. PubMed ID: 25545896
[TBL] [Abstract][Full Text] [Related]
10. How high are carrier frequencies of rare recessive syndromes? Contemporary estimates for Fanconi Anemia in the United States and Israel.
Rosenberg PS; Tamary H; Alter BP
Am J Med Genet A; 2011 Aug; 155A(8):1877-83. PubMed ID: 21739583
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive arrayed primer extension array for the detection of 59 sequence variants in 15 conditions prevalent among the (Ashkenazi) Jewish population.
Schrijver I; Külm M; Gardner PI; Pergament EP; Fiddler MB
J Mol Diagn; 2007 Apr; 9(2):228-36. PubMed ID: 17384215
[TBL] [Abstract][Full Text] [Related]
12. Molecular and genealogical evidence for a founder effect in Fanconi anemia families of the Afrikaner population of South Africa.
Tipping AJ; Pearson T; Morgan NV; Gibson RA; Kuyt LP; Havenga C; Gluckman E; Joenje H; de Ravel T; Jansen S; Mathew CG
Proc Natl Acad Sci U S A; 2001 May; 98(10):5734-9. PubMed ID: 11344308
[TBL] [Abstract][Full Text] [Related]
13. The Ashkenazi Jewish Fanconi anemia mutation: incidence among patients and carrier frequency in the at-risk population.
Whitney MA; Jakobs P; Kaback M; Moses RE; Grompe M
Hum Mutat; 1994; 3(4):339-41. PubMed ID: 8081385
[TBL] [Abstract][Full Text] [Related]
14. A common mutation in the FACC gene causes Fanconi anaemia in Ashkenazi Jews.
Whitney MA; Saito H; Jakobs PM; Gibson RA; Moses RE; Grompe M
Nat Genet; 1993 Jun; 4(2):202-5. PubMed ID: 8348157
[TBL] [Abstract][Full Text] [Related]
15. Coinheritance of BRCA1 and BRCA2 mutations with Fanconi anemia and Bloom syndrome mutations in Ashkenazi Jewish population: possible role in risk modification for cancer development.
Koren-Michowitz M; Friedman E; Gershoni-Baruch R; Brok-Simoni F; Patael Y; Rechavi G; Amariglio N
Am J Hematol; 2005 Mar; 78(3):203-6. PubMed ID: 15726604
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of breast and colorectal cancer in Ashkenazi Jewish carriers of Fanconi anemia and Bloom syndrome.
Baris HN; Kedar I; Halpern GJ; Shohat T; Magal N; Ludman MD; Shohat M
Isr Med Assoc J; 2007 Dec; 9(12):847-50. PubMed ID: 18210922
[TBL] [Abstract][Full Text] [Related]
17. Fanconi anemia in Ashkenazi Jews.
Kutler DI; Auerbach AD
Fam Cancer; 2004; 3(3-4):241-8. PubMed ID: 15516848
[TBL] [Abstract][Full Text] [Related]
18. Fanconi anemia: genetic testing in Ashkenazi Jews.
Auerbach AD
Genet Test; 1997; 1(1):27-33. PubMed ID: 10464622
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
